Wolfgang Eisterer

Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trial

Olivier Mir, Thomas Brodowicz, Antoîne Italiano et al. · The Lancet Oncology · 2016 · 279 citations

Medicine, Oncology, Pharmacology +7

CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factor

Reinhard Stauder, Wolfgang Eisterer, J. Thaler et al. · Blood · 1995 · 228 citations · Full text

Medicine, Hematology, Oncology +14

Previously undetected human hematopoietic cell populations with short-term repopulating activity selectively engraft NOD/SCID-β2 microglobulin–null mice

Hanno Glimm, Wolfgang Eisterer, K. Lee et al. · Journal of Clinical Investigation · 2001 · 194 citations · Full text

Medicine, Cell Biology, Hematology +11

Different subsets of primary chronic myeloid leukemia stem cells engraft immunodeficient mice and produce a model of the human disease

Wolfgang Eisterer, Xiaoyan Jiang, Oliver Christ et al. · Leukemia · 2005 · 136 citations

Medicine, Hematology, Oncology +15

Cisplatin and 5-fluorouracil with or without epidermal growth factor receptor inhibition panitumumab for patients with non-resectable, advanced or metastatic oesophageal squamous cell cancer: a prospective, open-label, randomised phase III AIO/EORTC trial (POWER)

Markus Moehler, Annett Maderer, Peter Thuss‐Patience et al. · Annals of Oncology · 2020 · 113 citations

Medicine, Oncology, Pharmacology +17